Literature DB >> 30415203

Impact of heart disease on maternal, fetal and neonatal outcomes in a low-resource setting.

Andrea Beaton1,2, Emmy Okello3, Amy Scheel4, Alyssa DeWyer4, Renny Ssembatya5, Olivia Baaka5, Henrietor Namisanvu5, Angela Njeri5,6, Alphons Matovu6, Imelda Namagembe7, Robert Mccarter4, Jonathan Carapetis8, Kristen DeStigter9, Craig Sable4.   

Abstract

BACKGROUND: The burden of pre-existing cardiovascular disease and the contribution to adverse pregnancy outcomes are not robustly quantified, particularly in low-income countries. We aimed to determine both the prevalence of maternal heart disease through active case finding and its attributable risk to adverse pregnancy outcomes.
METHODS: We conducted a 24-month prospective longitudinal investigation in three Ugandan health centres, using echocardiography for active case finding during antenatal care. Women with and without heart disease were followed to 6 weeks post partum to determine pregnancy outcomes. Prevalence of heart disease was calculated. Per cent attributable risk estimates were generated for maternal, fetal and neonatal mortality.
RESULTS: Screening echocardiography was performed in 3506 women. The prevalence of heart disease was 17 per 1000 women (95% CI 13 to 21); 15 per 1000 was rheumatic heart disease. Only 3.4% of women (2/58) had prior diagnosis. Cardiovascular complications occurred in 51% of women with heart disease, most commonly heart failure. Per cent attributable risk of heart disease on maternal mortality was 88.6% in the exposed population and 10.8% in the overall population. Population attributable risk of heart disease on fetal death was 1.1% and 6.0% for neonatal mortality
CONCLUSIONS: Occult maternal heart disease may be responsible for a substantial proportion of adverse pregnancy outcomes in low-resource settings. Rheumatic heart disease is, by far, the most common condition, urging global prioritisation of this neglected cardiovascular disease. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  global health; pregnancy; valvular heart disease

Year:  2018        PMID: 30415203     DOI: 10.1136/heartjnl-2018-313810

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  12 in total

Review 1.  Rheumatic heart disease: current status of diagnosis and therapy.

Authors:  Ferande Peters; Ganesan Karthikeyan; Jessica Abrams; Lorrein Muhwava; Liesl Zühlke
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

Review 2.  Acute Rheumatic Fever and Rheumatic Heart Disease: Highlighting the Role of Group A Streptococcus in the Global Burden of Cardiovascular Disease.

Authors:  Tangeni Auala; Ben'Lauro Goncalves Zavale; Amam Çhinyere Mbakwem; Ana Olga Mocumbi
Journal:  Pathogens       Date:  2022-04-21

3.  Global burden of rheumatic heart disease: trends from 1990 to 2019.

Authors:  Zejin Ou; Danfeng Yu; Yuanhao Liang; Jinhua Wu; Huan He; Yongzhi Li; Wenqiao He; Yuhan Gao; Fei Wu; Qing Chen
Journal:  Arthritis Res Ther       Date:  2022-06-11       Impact factor: 5.606

4.  The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study.

Authors:  Sonia Voleti; Emmy Okello; Meghna Murali; Rachel Sarnacki; Albert Majwala; Renny Ssembatya; Olivia Bakka; Henriator Namisanvu; Angela Njeri; Alphonsus Matovu; Kristen DeStigter; Craig Sable; Andrea Beaton
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-09       Impact factor: 3.007

5.  Caring for Pregnant Women with Rheumatic Heart Disease: A Qualitative Study of Health Service Provider Perspectives.

Authors:  Geraldine Vaughan; Angela Dawson; Michael Peek; Jonathan Carapetis; Vicki Wade; Elizabeth Sullivan
Journal:  Glob Heart       Date:  2021-12-22

6.  Modelling study of the ability to diagnose acute rheumatic fever at different levels of the Ugandan healthcare system.

Authors:  Emma Ndagire; Nicholas Ollberding; Rachel Sarnacki; Murali Meghna; Jafesi Pulle; Jenifer Atala; Collins Agaba; Rosemary Kansiime; Asha Bowen; Chris T Longenecker; Linda Oyella; Joselyn Rwebembera; Emmy Okello; Tom Parks; Huaiyu Zang; Jonathan Carapetis; Craig Sable; Andrea Z Beaton
Journal:  BMJ Open       Date:  2022-03-22       Impact factor: 2.692

Review 7.  Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum.

Authors:  Joselyn Rwebembera; Bruno Ramos Nascimento; Neema W Minja; Sarah de Loizaga; Twalib Aliku; Luiza Pereira Afonso Dos Santos; Bruno Fernandes Galdino; Luiza Silame Corte; Vicente Rezende Silva; Andrew Young Chang; Walderez Ornelas Dutra; Maria Carmo Pereira Nunes; Andrea Zawacki Beaton
Journal:  Pathogens       Date:  2022-01-28

8.  Outcomes and Care Quality Metrics for Women of Reproductive Age Living With Rheumatic Heart Disease in Uganda.

Authors:  Andrew Y Chang; Juliet Nabbaale; Emmy Okello; Isaac Ssinabulya; Michele Barry; Andrea Z Beaton; Allison R Webel; Chris T Longenecker
Journal:  J Am Heart Assoc       Date:  2020-04-16       Impact factor: 5.501

9.  Decision-to-delivery interval of emergency cesarean section in Uganda: a retrospective cohort study.

Authors:  Noemi J Hughes; Imelda Namagembe; Annettee Nakimuli; Musa Sekikubo; Ashley Moffett; Charlotte J Patient; Catherine E Aiken
Journal:  BMC Pregnancy Childbirth       Date:  2020-05-27       Impact factor: 3.007

10.  Establishment of a cardiac telehealth program to support cardiovascular diagnosis and care in a remote, resource-poor setting in Uganda.

Authors:  Alyssa DeWyer; Amy Scheel; Jenipher Kamarembo; Rose Akech; Allan Asiimwe; Andrea Beaton; Bua Bobson; Lesley Canales; Kristen DeStigter; Dhruv S Kazi; Gene F Kwan; Chris T Longenecker; Peter Lwabi; Meghna Murali; Emma Ndagire; Judith Namuyonga; Rachel Sarnacki; Isaac Ssinabulya; Emmy Okello; Twalib Aliku; Craig Sable
Journal:  PLoS One       Date:  2021-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.